MAPT and Alzheimer disease: Our group also demonstrated that hiPSC-iNs derived from an AD patient with the APP_D678H mutation show no significant changes in neuronal morphology, gene expression levels, and AD pathological characteristics, such as Aβ accumulation and Tau protein hyperphosphorylation, during differentiation and early maturation, even compared to its isogenic controls (Figure 2C–G).